An update of US Preventive Services Task Force guidelines on aspirin and cardiovascular disease is published in the latest Annals of Internal Medicine, based on new evidence published since 2002. The guideline focuses on new evidence on the benefits and harms of aspirin for the primary prevention of cardiovascular disease, including myocardial infarction and stroke.
Cardiovascular disease is a leading cause of death and it is the underlying or contributing cause in over 50% of deaths per year. In 2003, 1 of every 3 adults had some form of cardiovascular disease and in adults older than 40 years, the lifetime risk is 2 in 3 for men and more than 1 in 2 for women.
No comments:
Post a Comment